INNOCARE (09969) spent HK$2.4395 million to repurchase 426,000 shares on January 22nd.

22/01/2025

GMT Eight

INNOCARE (09969) announced on January 22, 2025 that they will spend 2.4395 million Hong Kong dollars to repurchase 42,600 shares, at a repurchase price of 5.66-5.74 Hong Kong dollars per share.

Shenzhen Longli Technology (300752.SZ) forecasts a net profit of 100 million to 120 million yuan for the year, an increase of 118.94% to 162.73% year-on-year.

Zhonghong Pulin Medical Products (300981.SZ) forecasts a net loss of 74 million to 111 million yuan for the year.

Contact: contact@gmteight.com

INNOCARE (09969) spent HK$2.4395 million to repurchase 426,000 shares on January 22nd.

RECOMMEND

Changzhou Architectural Research Institute Group (301115.SZ) issued a profit warning, expecting a net profit of 10-15 million yuan for the 2024 fiscal year, a year-on-year decrease of 85.09%-90.06%.

Shanghai Fosun Pharmaceutical (600196.SH) plans to repurchase A-shares worth 300 million to 600 million yuan.

Cloud Live Technology Group (002306.SZ) predicts a net loss of 18-22 million yuan for the year 2024.